MedPath

Post-Extubation Assessment of Clinical Stability in ELBW Infants

Recruiting
Conditions
Extremely Low Birth Weight Infants
Interventions
Device: Oxygen saturation probe
Device: Near infrared spectroscopy sensors
Device: Electrical impedance tomography
Registration Number
NCT06037083
Lead Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Brief Summary

This is an observational, proof-of-concept, feasibility study that aims to evaluate the feasibility of a monitoring system that integrates clinical data, high-resolution waveforms from the bedside monitor, regional oxygenation (via cerebral and splanchnic near-infrared spectroscopy), and regional ventilation (via electrical impedance tomography) from 20 extremely low birth weight infants at high-risk of reintubation.

Detailed Description

The primary aim of this proof-of-concept study is to evaluate the feasibility and acceptance of a monitoring system that integrates clinical data and biomedical signals from multiple modalities in a cohort of extremely preterm infants at high-risk of clinical instability on non-invasive respiratory support.

Secondary aims will be to longitudinally describe peripheral oxygen saturation, cerebral oxygen saturation, splanchnic oxygen saturation and regional lung ventilation in extremely low birth weight infants with or without reintubation during the 7 days post extubation.

The application of this multimodal monitoring approach using both clinical and physiological data during the postextubation period will help by making the assessment of clinical stability more comprehensive, more objective, more accurate, more standardized, and more reflective of important end-organ function. Thus, the proposed multimodal monitoring could lead to more informed decisions about reintubation and more individualized treatment plans during this critical period, hence potentially leading to better outcomes.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Birth weight < 1000g and gestational age < 28+0 weeks,
  • Received mechanical ventilation within the first 72h of life,
  • Undergoing their first planned extubation within the first 6 weeks of life.
Exclusion Criteria
  • Congenital anomalies and congenital heart disorders.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
20 extremely low birth weight infantsOxygen saturation probeIn addition to the standard care, all participants will be monitored using an extra oxygen saturation probe, two near infrared spectroscopy sensors, and an electrical impedance tomography belt. Data will be continuously collected from extubation to 168 hours postextubation
20 extremely low birth weight infantsNear infrared spectroscopy sensorsIn addition to the standard care, all participants will be monitored using an extra oxygen saturation probe, two near infrared spectroscopy sensors, and an electrical impedance tomography belt. Data will be continuously collected from extubation to 168 hours postextubation
20 extremely low birth weight infantsElectrical impedance tomographyIn addition to the standard care, all participants will be monitored using an extra oxygen saturation probe, two near infrared spectroscopy sensors, and an electrical impedance tomography belt. Data will be continuously collected from extubation to 168 hours postextubation
Primary Outcome Measures
NameTimeMethod
Acceptability of the multimodal monitoring approach168 hours

Acceptability of the multimodal monitoring approach will be evaluated using short anonymous surveys distributed to parents, bedside nurses, and attending clinicians participating in the study.

Recruitment rate168 hours

To evaluate the time frame needed to recruit patients and percentage of eligible infants recruited

Consent rate168 hours

To evaluate the percentage of eligible infants consented

Secondary Outcome Measures
NameTimeMethod
To describe longitudinal peripheral blood oxygen saturation patterns for infants with and without reintubation during the 7 days post-extubation168 hours

The variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation, and compared between infants requiring reintubation and those not requiring reintubation during the 7 days after extubation.

To describe longitudinal cerebral oxygen saturation patterns for infants with and without reintubation during the 7 days post-extubation168 hours

The variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation, and compared between infants requiring reintubation and those not requiring reintubation during the 7 days after extubation.

To describe longitudinal splanchnic oxygen saturation patterns for infants with and without reintubation during the 7 days post-extubation168 hours

The variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation. Repeated measures one-way ANOVA or Friedman test will be used to evaluate for differences in the variables over time.

To describe regional lung ventilation from the immediate pre-extubation period until 72-96 hours post-extubation.96 hours

The variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation. Repeated measures one-way ANOVA or Friedman test will be used to evaluate for differences in the variables over time.

Trial Locations

Locations (2)

McGill University Health Center

🇨🇦

Montreal, Quebec, Canada

Centre Hospitalier Universitaire Sainte-Justine

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath